The study of molecular changes induced by carnitines highlighted that both carnitine formulations positively modulated the antioxidant and glycative adaptive response of PCOS mouse ovaries, regulated by SIRT1 [124], and promoted the potentiation of mitochondria by modulating the expression of the mitochondrial transcription factor A (mtTFA), SIRT3, and SOD2. Here, TFAM is linked to polycystic ovary syndrome.